Cargando…
Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307212/ https://www.ncbi.nlm.nih.gov/pubmed/31110029 http://dx.doi.org/10.1136/annrheumdis-2019-215641 |
_version_ | 1783548768883310592 |
---|---|
author | van Mulligen, Elise Hazes, Johanna M W Weel, Angelique E A M de Jong, Pascal H P |
author_facet | van Mulligen, Elise Hazes, Johanna M W Weel, Angelique E A M de Jong, Pascal H P |
author_sort | van Mulligen, Elise |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7307212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73072122020-06-23 Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al van Mulligen, Elise Hazes, Johanna M W Weel, Angelique E A M de Jong, Pascal H P Ann Rheum Dis Correspondence Response BMJ Publishing Group 2020-07 2019-05-20 /pmc/articles/PMC7307212/ /pubmed/31110029 http://dx.doi.org/10.1136/annrheumdis-2019-215641 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Response van Mulligen, Elise Hazes, Johanna M W Weel, Angelique E A M de Jong, Pascal H P Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al |
title | Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
|
title_full | Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
|
title_fullStr | Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
|
title_full_unstemmed | Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
|
title_short | Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
|
title_sort | response to: ‘tara study: a new perspective on tapering drugs in ra’ by mishra et al |
topic | Correspondence Response |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307212/ https://www.ncbi.nlm.nih.gov/pubmed/31110029 http://dx.doi.org/10.1136/annrheumdis-2019-215641 |
work_keys_str_mv | AT vanmulligenelise responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal AT hazesjohannamw responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal AT weelangeliqueeam responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal AT dejongpascalhp responsetotarastudyanewperspectiveontaperingdrugsinrabymishraetal |